Maternal Screening and Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus
NCT03695029
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
120
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis B Virus Infection
Interventions
DRUG:
Tenofovir Alafenamide
Sponsor
National Taiwan University Hospital